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Abstract
Background: The xanthophyll astaxanthin is a high-value compound with applications in the nutraceutical,
cosmetic, food, and animal feed industries. Besides chemical synthesis and extraction from naturally producing
organisms like Haematococcus pluvialis, heterologous biosynthesis in non-carotenogenic microorganisms like
Escherichia coli, is a promising alternative for sustainable production of natural astaxanthin. Recent achievements in
the metabolic engineering of E. coli strains have led to a significant increase in the productivity of carotenoids like
lycopene or b-carotene by increasing the metabolic flux towards the isoprenoid precursors. For the heterologous
biosynthesis of astaxanthin in E. coli, however, the conversion of b-carotene to astaxanthin is obviously the most
critical step towards an efficient biosynthesis of astaxanthin.
Results: Here we report the construction of the first plasmid-free E. coli strain that produces astaxanthin as the sole
carotenoid compound with a yield of 1.4 mg/g cdw (E. coli BW-ASTA). This engineered E. coli strain harbors
xanthophyll biosynthetic genes from Pantoea ananatis and Nostoc punctiforme as individual expression cassettes on
the chromosome and is based on a b-carotene-producing strain (E. coli BW-CARO) recently developed in our lab. E.
coli BW-CARO has an enhanced biosynthesis of the isoprenoid precursor isopentenyl diphosphate (IPP) and produces
b-carotene in a concentration of 6.2 mg/g cdw. The expression of crtEBIY along with the b-carotene-ketolase gene
crtW148 (NpF4798) and the b-carotene-hydroxylase gene (crtZ) under controlled expression conditions in E. coli BW-
ASTA directed the pathway exclusively towards the desired product astaxanthin (1.4 mg/g cdw).
Conclusions: By using the l-Red recombineering technique, genes encoding for the astaxanthin biosynthesis
pathway were stably integrated into the chromosome of E. coli. The expression levels of chromosomal integrated
recombinant biosynthetic genes were varied and adjusted to improve the ratios of carotenoids produced by this E.
coli strain. The strategy presented, which combines chromosomal integration of biosynthetic genes with the
possibility of adjusting expression by using different promoters, might be useful as a general approach for the
construction of stable heterologous production strains synthesizing natural products. This is the case especially for
heterologous pathways where excessive protein overexpression is a hindrance.
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Xanthophylls comprise the group of oxygenated carote-
noids that are synthesizedb ym a n yp h o t o s y n t h e t i c
organisms and also by some non-photosynthetic yeasts,
fungi, and bacteria via condensation of isoprenoid units
and subsequent oxidation reactions. The xanthophyll
astaxanthin (3,3’-dihydroxy-b,b-carotene-4,4’-dione) has
gained considerable attention due to its beneficial effect
on human health. It has been shown that astaxanthin
bears a strong antioxidant and singlet oxygen-quenching
activity [1] which can modulate biological functions ran-
ging from lipid peroxidation to tissue protection against
UV-light damage [2]. Preclinical studies have further
shown that astaxanthin exhibits anti-inflammatory prop-
erties and reduces rethrombosis after thrombolysis [3].
Even more than the encouraging beneficial health prop-
erties, astaxanthin is used as a food colorant. The red-
orange color of astaxanthin is closely connected with
the quality of salmon or trout, for example. Therefore,
the supplementation of astaxanthin or other carotenoids
to their diets improves their value. Furthermore, the
natural carotenoids in the diet of fish play an important
role in reproduction [4].
Besides chemical synthesis or extraction from natu-
rally producing organisms like the green algae Haemato-
coccus pluvialis or the yeast Xanthophyllomyces
dendrorhous [5], the use of non-carotenogenic microor-
ganisms like Escherichia coli as a heterologous biosynth-
esis host is a promising alternative for the sustainable
production of natural astaxanthin. Recent achievements
in metabolic engineering of E. coli and yeast strains
have led to a significant increase in the productivity of
isoprenoid compounds (in particular terpenoids and car-
otenoids), by increasing the metabolic flux towards the
isoprenoid precursors [6-11]. For the heterologous bio-
synthesis of astaxanthin, however, the complete conver-
sion of b-carotene to astaxanthin is obviously the most
critical step towards an efficient biosynthesis of astax-
anthin in E. coli [12-14]. The conversion of b-carotene
to astaxanthin requires the introduction of keto-groups
at 4 and 4’ as well as hydroxyl-groups at 3 and 3’posi-
tions of the b-ionone rings. The addition of the keto
groups is catalyzed by the b-carotene ketolase, which is
encoded by crtO or by crtW genes [14,15]. The intro-
duction of the hydroxyl groups is catalyzed by the b-car-
otene hydroxylase. There are three known isoforms of
this enzyme: CrtZ, CrtR, and cytochrome-P450 hydroxy-
lase [16-19]. The isoforms of b-carotene ketolase and b-
carotene hydroxylase as well as their variants from dif-
ferent organisms show differences in their substrate spe-
cificity concerning the 3-hydroxylation or 4-ketolation
status of the b-ionone rings. As a result, the expression
of ketolase and hydroxylase in naturally producing
organisms as well as in a heterologous host leads to the
formation of up to eight intermediates beside astaxanthin.
See Figure 1 for details of astaxanthin biosynthesis in a
non-carotinogenic strain like E. coli. E. coli produces far-
nesyl pyrophosphate (FPP) as an isoprenoid precursor that
can be further converted to astaxanthin by heterologous
biosynthetic genes. In the cyanobacterium Nostoc punti-
forme PCC73102 two different genes of the crtW-type
were found (NpF4798 (crtW148), NpF5919 (crtW38)). The
recombinant enzymes CrtW38 and CrtW148 are both
able to convert b-carotene into canthaxanthin, but only
CrtW148 converts zeaxanthin into astaxanthin [20]. Simi-
lar observations have been made in the case of hydroxylase
enzymes. CrtZ from Pantoea ananatis is able to introduce
hydroxyl-groups into the b-ionone rings regardless of the
presence of keto-groups in 4 and 4’ positions [12]. The
structurally different hydroxylases from cyanobacteria are
not able to convert echinenone or canthaxanthin into
astaxanthin [21].
At present, no recombinant xanthophyll-producing E.
coli host has been reported that is able to accumulate
astaxanthin as the sole carotenoid compound. However,
significant improvements have been achieved by protein
engineering of the b-carotene ketolase. By using random
mutagenesis, crtW mutants form Paracoccus sp.a n d
Sphingomonas sp., were generated that showed an up to
81% [22] and 90% [23] production of astaxanthin,
respectively, when expressed in zeaxanthin-producing E.
coli strains.
So far, all studies on the formation of xanthophyll
compounds in E. coli use plasmids for the expression of
the heterologous genes. To avoid the use of recombi-
nant plasmids and to allow dispensing with selection
makers like antibiotics, we present here a strain harbor-
ing the biosynthetic genes crtE, crtB, crtI, crtY,a n dcrtZ
from P. ananatis and crtW148 (NpF4798) from N. punc-
tiforme PCC 73102 that are required for the formation
of astaxanthin in E. coli stably inserted into the chromo-
some, along with an enhanced expression of the native
E. coli genes idi and dxs. This strain is based on a b-car-
otene-producing basis strain (E. coli BW-CARO)
recently developed in our lab [24]. Furthermore, by bal-
ancing the expression of crtZ and crtW148,w h i c hw a s
determined by reverse transcription quantitative real-
time polymerase chain reaction (RT-qPCR), a plasmid-
free E. coli strain was engineered that accumulated
astaxanthin as the exclusive carotenoid.
Materials and methods
Bacterial strains, media, and chemicals
All strains and plasmids used or constructed in this study
are listed in table 1. The bacterial strains used in this
study were Escherichia coli BW-CARO [24] and E. coli
DH5a. If not stated otherwise, strains of E. coli were
grown at 37°C in LB medium. The minimal medium
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Page 2 of 12used had the following composition: KH2PO4 3gL
-1,
K2HPO4 12 g L
-1,( N H 4)2SO4 5gL
-1, MgSO4 ×7 H 2O0 . 3
gL
-1,C a C l 2 ×2 H 2O0 . 0 1 5gL
-1,N a C l0 . 1gL
-1,G l u c o s e
monohydrate 5 g L
-1,F e S O 4 ×7 H 2O/sodium citrate 15
ml L
-1 (from the solution of 7.5 g L
-1 FeSO4 ×7 H 2Oa n d
100 g L
-1 sodium citrate), thiamine, trace elements [25]
33 ml L
-1. Antibiotics were used at the following final
concentrations: ampicillin 100 μgm l
-1, chloramphenicol
50 μgm l
-1. Difco MacConkey agar base was purchased
from Nordwald (Hamburg, Germany). Carotenoid stan-
dards were provided by the Institute of Technical Bio-
chemistry, University of Stuttgart. All other chemicals
and reagents are from Sigma-Aldrich or Roth (Germany)
and were of the highest available purity.
Construction of plasmids
The crtW148 reading frame was obtained from plasmid
pPQE32-148 [20]. After NdeI/HindIII digestion, the
fragment was ligated into NdeI/HindIII digested
pJF119ΔN [26] and transformed into E. coli DH5a.T h e
resulting plasmid pJF119-crtW148 was further treated
with HindIII and ligated with a HindIII digested FRT-
cat-FRT fragment derived from plasmid pCAS30-FRT-
cat-FRT [27].
The reading frame of crtZ w a si s o l a t e df r o mp l a s m i d
pJF119-crtZ [24] after NdeI/BamHI treatment and
cloned into pAW223 [NdeI/BamHI]. The resulting plas-
mid pAW-crtZ was further treated with HindIII and
ligated with a HindIII digested FRT-cat-FRT fragment.
The DNA sequence of idi was amplified by polymerase
chain reaction (PCR) from chromosomal DNA of E. coli
LJ110 using the following oligonucleotides: a) GTGA-
GAACATATGCAAACGGAACACGTC b) CAAATGT-
CGGGATCCTTTTATTTAAGCTGGG. The PCR-
product was treated with NdeIa n dBamHI and was
ligated into expression vector pJF119ΔNh y d r o l y z e d
Figure 1 Scheme of the putative astaxanthin biosynthesis pathway in recombinant E. coli, proceeding from the central intermediates
pyruvate (Pyr) and glyceraldehyde-3-phosphate (GAP), highlighting the different possible routes of ketolase and hydroxylase reaction
that can take place by the conversion of b-carotene (1) to astaxanthin (10). Dxs 1-deoxyxylulose-5-phosphate synthase, Idi isopentenyl
diphosphate isomerise, IspA farnesyl diphosphate synthase, CrtE geranylgeranyl diphosphate synthase, CrtB phytoene synthase, CrtI phytoene
desaturase, CrtY lycopene cyclase, W b-carotene ketolase (CrtW), Z b-carotene hydroxylase (CrtZ), IPP isopentenyl diphosphate, DMAPP
dimethylallyl diphosphate, DXP 1-deoxyxylulose-5-phosphate, (2) b-cryptoxanthin, (3) echinenone, (4)3 ’-hydroxyechinenone, (5)3 -
hydroxyechinenone, (6) zeaxanthin, (7) canthaxanthin, (8) adonixanthin, (9) adonirubin.
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was further treated with HindIII and ligated with a Hin-
dIII digested FRT-cat-FRT fragment to gain plasmid
pJF119-idi- FRT-cat-FRT.
The dxs promoter replacement was conducted accord-
ing to the method used by Yuan et al [28]. Thus, for the
construction of pQE31-FRT-cat-FRT, the DNA
sequence of FRT-cat-FRT was amplified by PCR from
plasmid pCAS30-FRT-cat-FRT by using the following
oligonucleotides: a) CACAGACTGAGGATCCTCGA-
GAGTCGACCTGCAGG and b) CTGTTTTATCA-
GACCGCTCGAGCGTTCTGATTTA. The PCR
product was hydrolyzed with XhoI and ligated into the
XhoI hydrolyzed plasmid pQE31.
Chromosomal integration
The individual expression cassettes of idi, crtW148,a n d
crtZ from plasmid pJF-idi- FRT-cat-FRT, pJF-crtW-
FRT-cat-FRT, and pAW-crtZ-FRT-cat-FRT, respectively,
were amplified by PCR. The oligonucleotide primers
for the Ptac-crtW expression cassette were: 1)
CGGCGCATATTGCCCTGATGGACATTGACCCCA-
CCCGCCTGGAAGAGTCGCATATTGTTCAAGGCG-
CACTCCCGTTCTGG and 2) AGCGCAACGATGGCT-
TTAAGTGTCAGATGGCTTCCTTCAGCAGACGG-
TTGATTGTCTGCAGGGTTATTGTCTCATGAGCG.
Primers for the Prha-crtZ expression cassette were:
ACCGTTCTTAATTCTGATATTTCATCGGTGAT-
CTCCCGTCTGGGACATACCGATATGCATGCATC-
GATCACCACAATT and ATTCACGCTAGCCCATA-
CACCACGACTTCCTAAAGTAATCAGTACAGTA-
CGGATACC CAGGGTTATTGTCTCATGAGCGGA-
TAC. Primers for the Ptac-idi expression cassette were:
TGCAGGCATGAAACCGCGTCTTTTTTCAGATA-
AAAAGCGCAATCAGTCGCTCAA GGCGCACTCCC-
GTTCTGG and TAACATTACTCAGCAATAAACTG-
ATATTCCGTCAGGCTGGAATAAGGATGGCCT
TCTGCTTAATTTGATGCCTG.
For the integration of the expression cassettes, the
purified PCR products were each transformed into E.
coli BW-CARO and its variant strain carrying plasmid
pKD46. Expression of the l-Red enzymes and the pre-
paration of competent cells were carried out as
described previously [29]. Competent cells were electro-
porated with 0.2-0.4 μg of PCR product. After electro-
poration, the cells were resuspended in 1 ml LB-
medium and incubated at 30°C for 12 h with shaking.
Subsequently, the cell suspension was spread onto Mac-
Conkey-agar plates containing chloramphenicol and 1%
of the respective sugar (D-galactose, D-ribose, or meli-
biose), corresponding to the targeted genes responsible
for sugar degradation. MacConkey agar plates were
incubated over-night at 37°C. 5-10 pale colonies per
transformation were picked [24] and checked regarding
Table 1 Bacterial strains and plasmids
Strains Relevant genotype or sequences Source
E. coli DH5a F
-, j80d, lacZΔM15, endA1, recA1, hsdR17(rK
-mK
-), supE44, thi-1, gyrA96, relA1, Δ(lacZYA-argF)U169 laboratory strain
E. coli BW-CARO E. coli BW25113, malEG::crtE, fucIK::crtB,
xylAB::crtI, lacZA::crtY
[24]
E. coli BW-CAROdxs E. coli BW25113, malEG::crtE, fucIK::crtB,
xylAB::crtI, lacZA::crtY,P T5-dxs
this study
E. coli BW-CAROdxs-idi E. coli BW25113, malEG::crtE, fucIK::crtB,
xylAB::crtI, lacZYA::crtY,P T5-dxs, galEM::idi
this study
E. coli BW-CANT E. coli BW25113, malEG::crtE, fucIK::crtB,
xylAB::crtI, lacZA::crtY,P T5-dxs, galEM::idi, melAB::crtW148
this study
E. coli BW-ASTA E. coli BW25113, malEG:: Ptac-crtE, fucIK::Ptac-crtB,
xylAB::Ptac-crtI, lacZA::Ptac-crtY,P T5-dxs, galEM:: Ptac-idi, melAB::Ptac-crtW148, rbsDK::Prha-crtZ
this study
Plasmids
pKD46 ParaB gbexo (red recombinase), Amp
R [29]
pPQE32-148 pPQE32, N. punctiforme PCC 73102 crtW148148 gene, Amp
R [20]
pJF119ΔN cloning vector, RBS, Ptac, Amp
R [26]
pCAS1 pET11a, P. putida KT2440 hpd gene, Amp
R, [26]
pJF119-idi pJF119ΔN, E. coli idi gene, Amp
R this study
pJF119-idi-FRT-cat-FRT pJF119ΔN, E. coli idi gene, FRT-sites, Amp
R,C m
R this study
pQE31 cloning vector, RBS, PT5, Amp
R Qiagen, Germany
pCAS30-FRT-cat-FRT pJF119ΔN, P. ananatis crtE gene, FRT-sites, Amp
R,C m
R [27]
pJF119-crtW148 pJF119ΔN, N. punctiforme crtW148 gene, Amp
R, this study
pJF119-crtW148-FRT-cat-FRT pJF119ΔN, N. punctiforme crtW148 gene, FRT-sites, Amp
R,C m
R this study
pAW-crtZ pAW223, P. ananatis crtZ gene, Amp
R this study
pAW-crtZ-FRT-cat-FRT pAW223, P. ananatis crtZ gene, FRT-sites, Amp
R,C m
R this study
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nicol resistance cassette was eliminated using the plas-
mid pCP20 as previously described [30].
Extraction and analysis of carotenoids
E. coli strains carrying carotenoid biosynthetic genes
were cultivated in shake flasks in 50 ml LB medium or
minimal medium. Cultivations were carried out at 30°C.
At an optical density (OD600) of 0.3 - 0.4 the cultures
were induced, if required, by addition of IPTG (0.5 mM,
final conc.) and/or L-rhamnose (0.2% w/v, final conc.).
Samples (1 ml) were withdrawn from cultures after dif-
ferent time points within a period of 48 h. The cells were
harvested by centrifugation, washed with cold water, and
subsequently extracted by vigorous shaking with acetone
(500 μl) for 15 min at 50°C. Insoluble components of the
extract were removed by centrifugation (20,000 × g).
HPLC analysis was performed on Dionex HPLC Instru-
ment (Idstein, Germany), installed with a Chromeleon
S o f t w a r e ,G i n aa u t o s a m p l e r ,P 5 8 0p u m p s ,a n dad i o d e
array detector. Products were analyzed by loading 50 μl
of the supernatant onto a C30-reverse-phase HPLC col-
umn (250 mm × 4.6 mm, 5 μm, YMC-Europa GmbH,
Dinslaken, Germany) attached with a guard column con-
taining matrix of the same material as the column. A sol-
vent flow rate of 1.0 ml/min was used. The solvents used
were Solvent A, consisting of MTBE (methyl-tert-buty-
lether)/methanol/water (19/80/1) and Solvent B, consist-
ing of MTBE/methanol/water (90/9/1). Gradient
conditions: equilibration conditions at 2% B; 0 to 22 min
linear gradient from 2% B to 100% B. The spectra of the
eluted carotenoids were recorded online with a Dionex
UVD340 diode array detector (200 - 600 nm).
Carotenoid compounds were identified by co-chroma-
tography using authentic standard compounds and by
analysis of its UV-Vis spectra.
For the quantification of the carotenoid compounds
the integrated peak areas were compared to HPLC stan-
dard curves of authentic standards.
Detection and quantification of crtW148 and crtZ
Although isoprenoid products of CrtW148 and CrtZ
were detected, neither enzyme activity tests nor SDS-
PAGE were able to verify the presence of these proteins.
Therefore, mRNA from crtW148 and crtZ was detected
by means of absolute RT-qPCR using an internal
standard.
(I) Generation of the internal standard
Internal hpd (hydroxyphenyl-pyruvate dioxygenase gene
from Pseudomonas putida) RNA standard was generated.
This was similar to a protocol published by Schuhmacher
et al. [31] with the following exceptions: as template for
the internal standard, pCAS1 was used [26].
(II) Sampling, total RNA isolation, and cDNA synthesis
E. coli BW-ASTA was cultivated in shaking flasks at 37°
C (140 rpm) either in LB; LB plus L-rhamnose [12
mM]; LB plus L-rhamnose [12 mM] and IPTG [0.5
mM] or in minimal medium (MM); MM plus IPTG [0.5
mM]; or MM plus IPTG [0.5 mM] and L-rhamnose [12
mM]. For transcript level quantification, samples from
the late exponential phase were taken. In total, two bio-
logical replicates were processed.
A cell number - OD correlation was generated by
counting E. coli BW-ASTA using a Neubauer counting
chamber. According to this correlation, 5 × 10
8 cells
were pipetted into twice the amount RNA protect bac-
teria reagent (Qiagen) and processed according to man-
ufacturer’s protocol to prevent RNA degradation. Prior
to RNA isolation, cell pellets were spiked with 10 μL
internal hpd standard RNA [6.3 × 10
9 copies/μL]. RNA
was isolated using RNeasy Mini Kit (Qiagen, Hilden,
Germany). On-column DNAse digestion was performed
using RNase-free DNase set from Qiagen. RNA concen-
tration and quality were assessed photometrically
(NanoDrop ND 1000) and analyzed using the Agilent
Bioanalyzer 2100. In total, RNA concentrations ranged
from 396 ng/μL to 710 ng/μL. Only RNA with 260/280
nm ratios of 1.8 to 2.0 and 260/230 nm ratios greater
than 1.8 were used for reverse transcription. Reverse
transcription (RT) of 1 μgt o t a lR N Aw a sp e r f o r m e d
using QuantiTect Rev. Transcription Kit (Qiagen, Hil-
den, Germany) in a total volume of 20 μL according to
manufacturer’s protocol. cDNA was stored at -80°C
until further use.
(III) Quantitative real-time PCR
Quantitative real-time PCR (qPCR) primers were
designed using Roche’so n l i n eUniversal ProbeLibrary
(UPL) Assay Design Center (https://www.roche-applied-
science.com/sis/rtpcr/upl/index.jsp; Roche Applied
Science, Mannheim, Germany)). The specificity of pri-
mer pairs was checked using Basic Local Alignment
Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov/); for
primer sequences, hydrolysis probes and PCR efficiency
using plasmid or cDNA as template see Table 2. Primers
Table 2 Primer and hydrolysis probe sequences for qPCR, amplicon length and PCR efficiencies
Gene Primer 1 (5’ -3 ’) Primer 2 (5’ -3 ’) Amplicon length Hydrolysis probe Efficiency cDNA Efficiency plasmid
crtW148 ttgtgcccaaacaattagcc ttcctcgtggtagccaaaat 73 #119 1.88 1.83
crtZ cgatctttatgccgtggttt ggccacattcctgtactgc 72 #18 1.95 1.91
hpd ctatctgatcgaccgcttcg ccttcgatgaagttgaagtcg 66 #8 1.94 2
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(purification HPLC); hydrolysis probes were ordered
from Roche Applied Science, Mannheim, Germany.
qPCR was performed in a LightCycler
® 480 System
using LightCycler
® 480 multiwell plates 96 (white) and
the standard run protocol UPL (software: LightCycler
®
480 SW 1.5.0 - version 1.5.0.39). An absolute quantifica-
tion (method: Abs Quant/2nd Derivative Max) was per-
formed using plasmids pCAS1 (6718 bp, harboring hpd),
pJF119-crtZ (5905 bp, harboring crtZ,) and pJF119-
crtW148 (6038 bp, harboring crtW148)a ss t a n d a r d .A
dilution series of HindIII hydrolyzed plasmid DNA (10
9
-1 0
4 copies/μL) in triplicate was used for standard
curve generation. Copy number was calculated accord-
ing to Equation 1:
N =
NAxConc·hP
MWhP
(1)
with N: copies × μL
-1;N A: copies/mol (Avogadro con-
stant with 6.022 × 10
23 ×m o l
-1), Conc.hP: concentration
hydrolyzed plasmid (g × μL
-1); MW: molecular weight
(g × mol
-1)a n dM W hP: molecular weight hydrolyzed
plasmid.
(IV) Calculation of internal standard recovery and absolute
copy numbers
The recovery (r) of the internal RNA standard (hpd) was
calculated by dividing the experimentally determined
copy number (Nhpd,quant) of the internal standard by the
copy number of the internal standard (Nhpd,applied)o r i -
ginally used for spiking the samples multiplied with
dilution factor D (Equation 2):
r =
Nhpd,quant
Nhpd,appliedxD
(2)
where D is a dilution factor caused by the process of
RNA isolation, RT, and quantification by qPCR (see
Equation 3).
D =(
VRNAα
VRNAω
)x(
VRNA−>cDNA
VRNAω
)x(
VcDNA−>qPCR
VcDNA
) (3)
with VRNAa [L]: volume used for RNA isolation; VRNAω
[L]): sample volume after RNA isolation; VRNA->cDNA [L]:
RNA volume used for cDNA synthesis; VcDNA->qPCR [L]:
cDNA volume used for qPCR reaction and VcDNA [L]:
total volume of cDNA synthesis reaction. Absolute copy
numbers were calculated using Equation 4:
NmRNA,cell =
NmRNAα
r
(4)
with NmRNA, cell being the absolute copy number per
cell and NmRNAa being the copy number of the mRNA
of interest in total volume used for RNA isolation
(50 μL).
NmRNAa is calculated by Equation 5:
NmRNAα = NmRNA,quantx(
VcDNA
VcDNA−>qPCR
)x(
VRNAω
VRNA−>cDNA
)x(
VRNAα
VRNAω
) (5)
with NmRNA,quant: copy number estimated by qPCR.
Results
Construction of a b-carotene-producing strain
Recently our group developed a method for the integra-
tion of heterologous expression cassettes into the chro-
mosome of E. coli and the subsequent screening [24].
From this work resulted a plasmid-free strain (E. coli
BW-CARO) carrying the four genes crtEBIY from P.
ananatis in individual expression cassettes under the
control of IPTG inducible tac-promoters. To enhance
the expression level of the native 1-deoxyxylulose-5-
phosphate synthase gene (dxs), a rate-limiting enzyme of
the isoprenoid pathway [32], the native dxs promoter
was exchanged by the strong bacteriophage promoter
T5 [28]. First, a chloramphenicol resistance gene,
flanked by FRT sites, was cloned upstream of the T5-
promoter into pQE31. The resistance gene and promo-
ter region of the plasmid gained (pQE31-FRT-cat-FRT)
was PCR amplified and subsequently inserted upstream
of the native dxs in E. coli BW-CARO using the l-Red
recombineering technique. After elimination of the
resistance gene, the resulting strain E. coli BW-CARO-
dxs was further modified by the insertion of an addi-
tional copy of the native isopentenyl diphosphate iso-
merase gene (idi), a further rate-limiting enzyme of the
isoprenoid pathway [33]. The E. coli idi gene was cloned
into the expression vector pJF119ΔN and to allow tran-
sient selection for chromosomal integration, the cloned
gene was hooked up to a downstream chloramphenicol
resistance cassette. The expression cassette of the result-
ing plasmid pJF119-FRT-cat-FRT, including resistance
gene, was PCR amplified and transformed into E. coli
BW-CARO-dxs harboring the l-Red recombinase
expression plasmid pKD46. The selected PCR primers
led to the homologous recombination of the expression
cassette into the galactose locus (galETKM). The engi-
neered E. coli strains gained (E. coli BW-CARO, E. coli
BW-CARO-dxs,a n dE. coli BW-CARO-dxs-idi)w e r e
cultivated in complex medium and the carotenoid con-
tent was analyzed. All strains produce b-carotene as the
sole carotenoid (Figure 2A). As expected, the amount of
b-carotene increased due to the enhanced expression of
dxs and idi. The exchange of the native dxs promoter
by the T5-promoter in E. coli BW-CARO increased the
amount of b-carotene per cell by a factor of 2.6. After
insertion of the additional idi copy into E. coli BW-
CARO-dxs the amount of b-carotene per cell increased
by the factor of 1.9 (b-carotene content in E. coli BW-
CARO 1.24 ± 0.17 mg/g cellular dry weight (cdw);
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Page 6 of 12E. coli BW-CARO-dxs 3.254 ± 0.24 mg/g cdw; E. coli
BW-CARO-dxs-idi 6.18 ± 0.78 mg/g cdw).
Chromosomal integration of crtW and crtZ
T h er e a d i n gf r a m eo ft h eb-carotene ketolase gene
(crtW148) from N. punctiforme PCC73102 was amplified
from plasmid pQE32-148 and cloned into the expression
vector pJF119ΔN, resulting in plasmid pJF-crtW148. In
transformants of b-carotene-producing E. coli BW-
CARO-dxs-idi with pJF-crtW148 the di-keto carotenoid
canthaxanthin represented 85% (0.896 ± 0.12 mg/g cdw)
of the total carotenoid content with about 10% b-caro-
tene and small amounts of echinenone (Figure 2C). The
ratio of the three carotenoids did not vary during the 48
h cultivation. The addition of the inducer IPTG had
neither influence on the carotenoid formation nor on
growth (data not shown).
After cloning of a FRT-cat-FRT cassette into pJF-
crtW148, chromosomal integration of the Ptac-crtW148
expression cassette into the melibiose locus (melAB)o f
Figure 2 HPLC analysis of the carotenoids accumulated during cultivation of plasmid-free E. coli strains: A BW-CARO-dxs-idi in LB
medium (48 h), B BW-ASTA in LB medium (48 h), C BW-CANT in LB medium (48 h), D BW-ASTA in LB medium plus L-rhamnose (48 h), E BW-
ASTA in MM medium plus IPTG (24 h), F BW-ASTA in MM medium plus IPTG and L-rhamnose (48 h), G BW-ASTA in MM medium plus IPTG (48
h), H astaxanthin standard. Detection wavelength 470 nm. (1) b-carotene, (3) echinenone, (6) zeaxanthin, (7) canthaxanthin, (8) adonixanthin, (9)
adonirubin, (10) astaxanthin, (10’) cis-astaxanthin.
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resistance cassette, the engineered strain E. coli BW-
CANT showed an about 20% higher formation of
canthaxanthin (1.085 ± 0.15 mg/g cdw) but the percen-
tage of canthaxanthin of all carotenoids was 85% as in
the plasmid carrying strain E. coli BW-CARO-dxs-idi
pJF-crtW148. The addition of IPTG up to 1 mM into
LB-medium cultures of E. coli BW-CARO-dxs-idi pJF-
crtW148 and E. coli BW-CANT, respectively, did not
change the ratio of canthaxanthin, b-carotene, and echi-
nenone as well as the total carotenoid yield, which we
take as evidence of the leakiness of the tac-promoter in
LB-medium.
In order to engineer an astaxanthin-producing strain,
the b-carotene hydroxylase gene (crtZ) was inserted into
the chromosome of E. coli BW-CANT. To allow a vari-
able expression of crtZ compared to the tac-promoter
controlled biosynthetic genes, crtZ was expressed under
control of the rhamnose-promoter (PrhaBAD). For this
purpose crtZ was cloned from plasmid pJF119-crtZ into
pAW223. To verify the functional expression of this
construct, pAW-crtZ was introduced into b-carotene-
producing E. coli. Cultivation of E. coli BW-CARO-dxs-
idi pAW-crtZ and subsequent carotenoid analysis
showed that zeaxanthin was produced as the only caro-
tenoid product (1.48 mg/g cdw).
Cloning of a FRT-cat-FRT cassette into pAW-crtZ
and chromosomal integration of the PrhaBAD-crtZ
expression cassette into the ribose locus (rbsDABCK)o f
E. coli BW-CANT and elimination of the resistance cas-
sette resulted in the strain E. coli BW-ASTA, containing
all required biosynthetic genes for the formation of
astaxanthin as single expression units, respectively, on
the chromosome. Cultivation of E. coli BW-ASTA in
LB-medium showed that astaxanthin is the predominant
carotenoid product (71%). Besides astaxanthin, zeax-
anthin (25%) was the only other detectable carotenoid
(Figure 2B, Figure 3). The addition of the inducer L-
rhamnose to E. coli BW-ASTA cultures led to an
increase of zeaxanthin (69%) compared to astaxanthin
(20%) (Figure 2D, Figure 3). The enhanced expression of
crtZ by L-rhamnose induction therefore led to a signifi-
cant increase of zeaxanthin, obviously due to a low
activity of CrtW148 for the substrate zeaxanthin. The
induction of E. coli BW-ASTA LB medium cultures
with IPTG in the presence of 0.2% L-rhamnose or with-
out had neither effect on the amount of carotenoid nor
on the ratio of astaxanthin and zeaxanthin.
Controlled gene expression in E. coli BW-ASTA using
glucose-containing medium
In order to avoid the formation of zeaxanthin by E. coli
BW-ASTA, an increase of the ketolase activity or a
decrease of the hydroxylase activity would be necessary.
To better control the expression by the tac- and, in par-
ticular, by the rha-promoter that are both not tightly
controlled in LB-medium (see Figure 4), minimal med-
ium with glucose as C- and energy source was used.
The cultivation of E. coli BW-ASTA in minimal medium
without the addition of inducer molecules resulted in
the formation of only small amounts (0.11 mg/g cdw) of
astaxanthin, which we interpret as the result of the
higher repression of the tac-promoter in minimal med-
ium in contrast to LB-medium. On the other hand, the
addition of IPTG to the cultures, which induces the Ptac
controlled gene expression of dxs, idi, crtE, crtB, crtI,
crtY,a n dcrtW, resulted after 48 h in a 12-fold increase
in the formation of carotenoids. After 24 h of incubation
in minimal medium, E. coli BW-ASTA synthesized 0.96
± 0.14 mg/g cdw astaxanthin and the by-products ado-
nirubin (13%), canthaxanthin (12%), and b-carotene
(1%) (Figure 2E). In contrast to the cultivation in LB
medium no zeaxanthin formation was observed. After
an incubation time of 48 h astaxanthin was produced as
exclusive carotenoid (>95%) in a concentration of (2.07
± 0.15 mg/l; 1.41 ± 0.11 mg/g cdw) (Figure 3). This
result shows that during the cultivation of E. coli BW-
ASTA in minimal medium with glucose and IPTG the
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Figure 3 Production of zeaxanthin (A) and astaxanthin (B) by E.
coli BW-ASTA (in mg per liter of culture (rhomboid)) and in mg
per gram cellular dry weight (cdw; (square)) after cultivation
for 48 h under different conditions. Values represent the mean (n
= 4) ± standard deviation. * indicates significant changes between
un-induced (LB or MM) and induced state (LB Rha, LB IPTG or MM
IPTG, MM Rha IPTG, respectively). p ≤ 0.05, unpaired t-test assuming
unequal variances.
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ketolase (CrtW148) into cantaxanthin, which is subse-
q u e n t l ys l o w l yh y d r o x y l a t e db yC r t Z .T h ec o n c u r r e n t
addition of both inducers, IPTG and L-rhamnose, also
led after 24 h to the formation of astaxanthin (68%),
adonirubin (14%), cantaxanthin (12%), and traces of b-
carotene (1%). In the late stationary phase (48 h) of the
culture astaxanthin was still the predominant carotenoid
with >90%, however, the cells also contained about 5%
of zeaxanthin as a by-product (Figure 2F).
Transcriptional analysis of crtW148 and crtZ
In order to ascertain whether the assumed expression
levels of CrtW148 and CrtZ based on carotenoid forma-
tion by E. coli BW-ASTA were in accordance with the
mRNA levels of crtW148 and crtZ, we performed abso-
lute RT-qPCR studies. A method previously described
by Schuhmacher et al. [31] that uses an external stan-
dard for absolute transcript number quantification, was
adapted to the Roche UPL system allowing for absolute
transcript number determination per cell.
From the cultivation of E. coli BW-ASTA in LB med-
ium and in minimal medium, with or without induction
of the tac-a n drha-promoter, respectively, cells were
withdrawn in the late exponential phase and were ana-
lyzed for the crtZ and crtW148 transcript level by RT-
qPCR. The number of transcripts of crtW148 and crtZ
under the different conditions are shown in Figure 4. In
LB medium, comparable transcript numbers per cell
c o u l db ed e t e c t e df o rcrtW148 with or without IPTG
induction (between 22 ± 4 and 25 ± 1 copies/cell). A
15% higher copy number was detected for crtZ (41 ± 3
c o p i e s / c e l lc o m p a r e dt o4 8±5t o5 3±3c o p i e s / c e l l )
after induction with L-rhamnose. The transcript level of
crtZ reflects the formation of zeaxanthin when culti-
vated in complex medium. An increased expression of
crtZ correlated with an increased formation of zeax-
anthin by E. coli BW-ASTA. Under all cultivation condi-
tions in LB medium, zeaxanthin and astaxanthin had
been detected. By using glucose-containing minimal
medium the transcription of the heterologous genes was
more tightly regulated than in LB medium. Transcript
numbers per cell of crtW148 without the addition of
IPTG were 12 ± 1. For crtZ in average, less than one
copy number per cell was detected in minimal medium
without induction. This reflects the tight regulation of
the rhamnose-promoter under these conditions. These
results are in good accordance with the product forma-
tion; in minimal medium without induction, only small
amounts of astaxanthin as the sole carotenoid were
detected (Figure 3). The induction by IPTG led to a 2.3
to 2.6 fold increase in mRNA level of crtW148,a n d
resulted in a 20-fold increase of the carotenoid concen-
tration. Here, astaxanthin was the only carotenoid that
was accumulated by E. coli BW-ASTA after 48 h (Figure
2). This shows that the low mRNA level of crtZ yielded
in a sufficient amount of hydroxylase activity converting
all the produced precursors into astaxanthin. The addi-
tion of L-rhamnose led to a significant increase in tran-
script levels of crtZ (8.6 fold). In these cases, both
astaxanthin (90%) and zeaxanthin (5%) had been
detected as products after 48 h.
Discussion
The in vivo biosynthesis of a complex natural product in
a heterologous host like E. coli first requires the intro-
duction and the functional expression of biosynthetic
genes that enable the conversion of available cell inter-
mediates towards the desired product. The heterologous
biosynthesis of astaxanthin by E. coli has been achieved
in numerous studies by the expression of respective car-
otenoid biosynthetic genes using recombinant plasmids
[20,23,33-36]. In this study, we constructed a plasmid-
free E. coli strain that carries each of the astaxanthin
biosynthetic genes (crtE,B,I,Y,Z,W)a si n d i v i d u a le x p r e s -
sion units on the chromosome. For the integration of
the expression cassettes we used a method, recently
developed in our lab, that allows fast and reliable inte-
gration and screening [24]. It is based on the l-Red
mediated recombination technique developed for the
directed knock-out [29]. This method utilizes the repla-
cement of E. colis’ rare sugar degradation genes which
are dispensable for most biotechnological applications.
The replacement of these genes can easily be visualized
by the use of MacConkey differential agar medium car-
rying the corresponding sugar compound.
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(MM) and harvested in late exponential phase are shown. Rha:
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thetic genes has for obvious reasons some advantages
compared to the use of heterologous plasmids. Thus,
plasmids may be the best choice for the cloning and
short-term expression of recombinant genes, in particu-
lar for the maximum overproduction of a given protein.
Especially in metabolic engineering applications, how-
ever, a too strong gene expression may be unfavorable
for long-term productivity [37]. Yoon et al. [38]
observed that a high expression of lycopene biosynthetic
genes in E. coli leads to a decrease in growth and lyco-
pene production. Therefore, the chromosomal integra-
tion of heterologous expression cassettes can be
favorably compared to multi-copy plasmids in terms of
metabolic burden effects, structural instability, and most
important segregational instability [39]. Furthermore, a
stable chromosomal insertion obviates the use of selec-
tion-markers (e.g. antibiotics) that are commonly used
for the maintenance of plasmids during cultivation.
Especially antibiotics are both costly and can hamper
the product purification in food and pharmaceutical
production processes. On the other hand, a low enzyme
activity of a heterologous downstream pathway can
result in a reduced product yield or in an accumulation
of pathway intermediates [40]. Thus, the in vivo bio-
synthesis of carotenoids in E. coli requires an appropri-
ate heterologous gene expression, adapted to the supply
of isoprenoid precursors to avoid the effect of metabolic
burden and to avoid the accumulation of pathway inter-
mediates. The increased biosynthesis of b-carotene (up
to 6.2 mg/g cdw) by the enhanced expression of idi and
dxs in E. coli BW-CARO demonstrates that the expres-
sion of the heterologous biosynthetic genes and accord-
ingly the enzyme activity of the corresponding proteins
in this strain do not limit the formation of b-carotene.
Similar observations were made by Chiang et al. [41] for
a lycopene-producing strain that carries a single copy of
al y c o p e n eb i o s y n t h e t i cg e n ec l u s t e ro nt h ec h r o m o -
some. Surprisingly, the additional expression of crtW148
and crtZ in the b-carotene-producing strain reduced the
overall formation of carotenoids about three times com-
pared to E. coli BW-CARO-dxs-idi.T h i sl e a d st ot h e
suggestion that the recombinant proteins (CrtW148 or
CrtZ) or a product of their enzymatic reaction effect the
formation of the carotenoid precursors upstream of phy-
toene, because no other carotenoid accumulated in the
cell. This stands in contrast to the study by Scaife et al.
[36] who found that expression of a b-carotene-ketolase
and -hydroxylase within a b-carotene-producing strain
significantly increases the total carotenoid yield. The
maximum astaxanthin yield of almost 2 mg/g in this
study and ours is in the same range and represents the
highest astaxanthin content in E. coli that has been
achieved so far.
Besides the chromosomal integration, another aim of
our work was to find conditions by which E. coli synthe-
sizes astaxanthin as the sole carotenoid. For the conver-
sion of b-carotene to astaxanthin, the b-carotene
ketolase gene from Nostoc punctiforme (crtW148)a n d
the b-carotene hydroxylase gene from Pantoea ananatis
(crtZ) were chosen, because the corresponding proteins
(CrtW148, CrtZ; see Figure 1) are known to be bifunc-
tional and therefore accept b-carotene as well as hydro-
xylated or ketolated products, respectively, as substrate
[12,20]. In order to vary the expression level of crtW148
and crtZ, the hydroxylase gene was expressed under
control of the rha-promoter in contrast to the other
heterologous genes thatw e r ec o n t r o l l e db yatac-pro-
moter, respectively. The cultivation of E. coli BW-ASTA
in LB medium showed the formation of astaxanthin as
the predominant product but also a significant amount
of zeaxanthin that increased upon the additional induc-
tion of the rha-promoter. In contrast, the additional
IPTG induction of the crtW148 controlling tac-promo-
ter had no significant influence on the product forma-
tion. The carotenoid formation is in concordance with
the results of mRNA quantification. The qPCR measure-
ment showed that both, tac-promoter (crtW148)a n d
rha-promoter (crtZ) ,a r eo n l ym a r g i n a l l yr e p r e s s e d
under the given conditions (Figure 4).
It is supposed that hydroxylase and ketolase compete
for their substrate and that only a balanced expression
of these two enzymes might lead to a complete conver-
sion of b-carotene to astaxanthin [12,42-44]. This
hypothesis is supported by our results. We suppose that
in the astaxanthin biosynthesis by E. coli BW-ASTA the
hydroxylation reaction occurs fast with b-carotene as
well as with the ketolated intermediates as substrates.
No intermediates were detected under these conditions
which are mostly ketolated (Figure 2). The CrtW148
ketolase does utilize b-carotene and to a minor extent
hydroxylated intermediates. But during the course of
cultivation the ketolase was not able to convert the
accumulated zeaxanthin into adonixanthin or astax-
anthin, completely. Although the bifunctionality of
CrtW148 from N. punctiforme was proven [20], the con-
version of zeaxanthin to astaxanthin by CrtW148 is
obviously the most limiting step towards the efficient
biosynthesis of astaxanthin in our system. To improve
the conversion of zeaxanthin to astaxanthin, protein
engineering of a CrtW-type ketolase had been used suc-
cessfully, but a complete transformation to astaxanthin
was not achieved [22,23]. In contrast to this research,
our working hypothesis was to avoid the accumulation
of zeaxanthin by increasing the activity ratio of
CrtW148 to CrtZ not by enhanced crtW148 expression
or enzyme activity/specificity but instead by lowering
the crtZ expression level. This was achieved by the use
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better balanced regulation of both heterologous promo-
ters. Especially the rhamnose-promoter, that regulates
the expression of crtZ, is more tightly controlled by the
catabolite repression [45,46]. Cultivation of E. coli BW-
ASTA under this condition with induction of the IPTG-
controlled heterologous promoters led in the early phase
of the cultivation to the formation of astaxanthin and
the intermediates adonirubin and canthaxanthin (Figure
2) that vanished, presumably due to the transformation
into astaxanthin during the course of cultivation. We
take this as evidence that the adjustment of the expres-
sion level can direct the pathway towards the desired
product, astaxanthin. The low expression of crtZ and
the, in contrast, high expression of crtW148 (Figure 4)
make it obvious that the synthesized b-carotene is due
to the kinetics of the reactions, preferentially converted
into canthaxanthin, which is secondly completely trans-
formed by the slower hydroxylation reaction via adonir-
ubin into astaxanthin. Similar observations concerning
the competition between hydroxylase and ketolase have
been made for transgenic maize where plants harboring
only an endogenous hydroxylase but an exogenous keto-
lase gene under an endospecific promoter accumulated
astaxanthin. Astaxanthin, however, was not accumulated
by plants harboring both exogenous hydroxylase and
ketolase genes [44]. The authors indicated that the
avoidance of the adonixanthin accumulation is crucial
for astaxanthin production in transgenic maize endo-
sperm [44]. In contrast, we find the avoidance of zeax-
anthin accumulation to be the crucial step for sole
astaxanthin synthesis in the bacterium E. coli BW-
ASTA.
Conclusions
In this study, we engineered a plasmid-free E. coli strain
that carries biosynthetic genes for the in vivo biosynth-
esis of astaxanthin. The stable chromosomal insertion of
the heterologous genes enables dispensing with selection
makers that are required for the maintenance of recom-
binant plasmid. The biosynthetic genes were each inte-
grated as single expression units into the chromosome
of E. coli. This approach allows the control of individual
gene expression levels, which is complicated to achieve
if the astaxanthin biosynthetic genes are organized
within one operon. This E. coli engineering strategy
might also be useful as a general approach for the con-
struction of stable production strains for the heterolo-
gous biosynthesis of natural products for which
excessive protein overexpression is a hindrance.
The adjustment of the crtZ expression level in the
astaxanthin-producing strain was applied successfully
for the complete in vivo conversion of b-carotene into
astaxanthin by recombinant E. coli cells.
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